XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
  United States
  United Kingdom
  India
  ECFMG
  Australia
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

United States Channel
subscribe to United States newsletter

Careers : Medical : United States

   DISCUSS   |   EMAIL   |   PRINT
Jefferson Acquires Wills Eye Residency Programs
Jul 15, 2006, 19:21, Reviewed by: Dr. Priya Saxena

Subject to the terms of a License Agreement, the inpatient program will be known as Wills Eye at Jefferson and the residency program will be known as Wills Eye Residency Program at Jefferson.

 
Wills Eye Hospital of Philadelphia will transfer responsibility for its inpatient and ophthalmology residency programs to its longstanding partners, Thomas Jefferson University and Thomas Jefferson University Hospital, effective July 1, 2006.

�Jefferson and Wills have been affiliated for more than 30 years,� said Thomas J. Lewis, President and Chief Executive Officer, Thomas Jefferson University Hospital. �We are pleased to be able to strengthen our commitment to quality medical education, clinical care and research through the management of the inpatient and residency programs and at the same time continue to provide patients with high quality inpatient eye care.�

James Mulvihill, Chief Executive Officer of Wills Eye Hospital agreed, saying, �This move reflects the changing delivery model for eye care, in which increasing numbers of patients can be treated on an outpatient basis.� Mulvihill added, �Wills will continue to operate as an independent outpatient network, providing the world-class eye care its founder James Wills envisioned back in 1832.�

Inpatient ophthalmology services will continue to be offered at 900 Walnut Street in Philadelphia by Thomas Jefferson University Hospital. In addition, the Wills Eye Emergency Department will remain open at its current location at 900 Walnut Street for at least two years.

The transaction was approved by regulatory authorities including the Pennsylvania Department of Health.

Subject to the terms of a License Agreement, the inpatient program will be known as Wills Eye at Jefferson and the residency program will be known as Wills Eye Residency Program at Jefferson. Wills physicians providing inpatient ophthalmology services will serve as faculty members at Thomas Jefferson University and medical staff members at Thomas Jefferson University Hospital.
For the 17 th consecutive year, Wills was ranked as one of the top three Ophthalmology centers in the nation by U.S. News and World Report.
 

- Thomas Jefferson University
 

www.jefferson.edu

 
Subscribe to United States Newsletter
E-mail Address:

 



Related United States News

Jefferson Acquires Wills Eye Residency Programs
Major Increase in U.S. Medical School Enrollment
Renewed interest in young physicians to pursue research careers
Number Of Students In U.S. Medical Schools Remains Constant
Record Number Of Trainee Residents And Fellows In US
Virtual Celebration Encourages Exploration of Genomic Careers


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us